Viruses in animal-derived starting materials could contaminate biopharmaceutical final product. A rigorous testing strategy and removal methods are reviewed.
Kate Smith
Advertisement
Kate Smith is principal scientist, development services, at BioReliance, kate.smith@bioreliance.com
Articles by Kate Smith
Advertisement
Latest Updated Articles
Clearing Viral Concerns in Animal-Derived BiomaterialsPublished: August 1st 2013 | Updated:
Advertisement
Advertisement
